What is CSL in Australia?
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions.
Who owns CSL in Australia?
CSL, originally the Commonwealth Serum Laboratories, was established by the Australian Government in 1916 to service the needs of the Australian people. In 1991, paving the way for listing, the organisation was converted to a public company, 100% owned by the Federal Government and renamed CSL Limited.
What kind of company is CSL?
biopharmaceutical company
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products.
What companies does CSL own?
Over the past century, CSL Behring has acquired: Aventis Behring, U.S. plasma collector Nabi, which helped form the world’s largest plasma collection network in CSL Plasma; Calimmune, a leader in gene-modification and cell-delivery technology; and Vitaeris, a biopharmaceutical company focused on the development of …
Is CSL still owned by the Australian government?
In 1994 CSL Limited, formerly the Commonwealth Serum Laboratories, was sold to private investors for $299 million. CSL has been Australia’s principal supplier of vaccines and antivenoms since 1916 and the sole manufacturer of blood products.
What is CSL known for?
CSL Behring is a global biotechnology leader with the broadest range of quality medicines in the industry and substantial markets throughout the world. Our therapies are indicated for bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.
Is CSL an ethical investment?
At CSL, Corporate Responsibility (CR) is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities. We believe that behaving responsibly is critical to the sustainability of our company.
Is Australian Ethical not for profit?
Australian Ethical directs 10% of its profits (after tax, before bonuses and grant expenses) into the Australian Ethical Foundation, which supports charitable organisations and social impact initiatives. This is one of the highest ratios of corporate giving in Australia and something we are immensely proud of.
Is Australian Ethical a good super fund?
The Responsible Investment Association Australasia (RIAA), the accreditor of ethical investments, has certified only four funds as ethical on a whole-of-fund basis. Of these, Australian Ethical had the best performance over the past five years. The certified funds can be found through RIAA’s Responsible Returns tool.
Is CSL overvalued?
Compared to the current market price of 293.81 AUD, CSL Ltd is Overvalued by 34%.
Is CSL sustainable?
It defines our ethical standards and sets out our commitment to sustainable development. Sustainability is governed by CSL’s Executive Sustainability Committee. The Committee facilitates the development of our sustainability targets and drives awareness, integration and continuous improvement throughout the Company.
Why CSL is a good buy?
CSL is widely regarded to be one of the highest quality shares on the ASX 200. It is a biotherapeutics company that develops, manufactures, and sells a range of life-saving plasma therapies and vaccines. It is also in the process of acquiring Vifor Pharma for ~$17 billion.
Is CSL a good company to invest in?
Is CSL a good buy?
The team at Morgans see a lot of value in the CSL share price. In response to its half year results, last week the broker put an add rating and $327.60 price target on its shares. Based on the current CSL share price of $268.89, this implies potential upside of 22% for investors over the next 12 months.